文献速递肺栓塞与肺血管病

2026 AHA/ACC与2019 ESC风险分层对住院急性肺栓塞短期预后判别比较

Comparative Short-Term Prognostic Discrimination of the 2026 AHA/ACC and 2019 ESC Risk Classifications in Hospitalized Acute Pulmonary Embolism: A Retrospective Two-Campus Cohort Study.
PubMed 文献 · Chest · 2026-09-29

该回顾性双院区队列纳入2251例住院急性肺栓塞患者,比较2026 AHA/ACC与2019 ESC分类对30天全因死亡和肺栓塞相关死亡的判别能力。AHA/ACC的30天全因死亡AUC为0.885,高于ESC的0.763(差异0.122,P<.001),且识别出ESC中危层中30天死亡率高达75.7%的高危表型。

要点

  • AHA/ACC分类对30天全因死亡判别优于ESC(AUC 0.885 vs 0.763)。
  • AHA/ACC D-E对肺栓塞相关死亡敏感性83.8%,ESC高危层58.8%。
  • AHA/ACC D-E但ESC中危的37例患者30天死亡率达75.7%。

核心结论

  • 住院急性肺栓塞中,AHA/ACC分类较ESC分类对30天全因死亡和肺栓塞相关死亡显示出更好的全谱序贯判别能力。
  • AHA/ACC D-E识别出ESC未归为高危但观察死亡率很高的患者表型。
  • 去除AHA/ACC极端类别A和E后,AUC差异缩小,提示判别差异依赖疾病严重谱范围。

研究设计与样本

  • 回顾性双院区队列研究,纳入中国三级医院2013至2025年2251例住院急性肺栓塞患者。
  • 社区获得性肺栓塞以入院时间为索引,医院获得性以症状出现或首次客观影像时间为索引。
  • 主要结局为30天全因死亡,肺栓塞相关死亡由机构判定为事后分析。
  • 采用配对DeLong检验比较序数AUC,以AHA/ACC类别D-E定义分析用高危阈值。

主要发现

  • 127例(5.6%)在30天内死亡,80例(3.6%)发生肺栓塞相关死亡。
  • 30天全因死亡AUC:AHA/ACC 0.885(95%CI 0.858-0.912),ESC 0.763(95%CI 0.721-0.806),差异0.122(95%CI 0.084-0.160,P<.001)。
  • 肺栓塞相关死亡AUC:AHA/ACC 0.942,ESC 0.826,差异0.116(95%CI 0.068-0.164,P<.001)。
  • 分析定义高危阈值下,AHA/ACC D-E对肺栓塞相关死亡的敏感性83.8%、特异性95.1%;ESC高危层敏感性58.8%、特异性95.8%。
  • AHA/ACC D-E但ESC中危层的37例患者中,75.7%在30天内死亡,54.1%为肺栓塞相关死亡。

关键数值与推荐

  • 30天全因死亡AUC:AHA/ACC 0.885(95%CI 0.858-0.912)优于ESC 0.763(95%CI 0.721-0.806)。
  • 肺栓塞相关死亡AUC:AHA/ACC 0.942优于ESC 0.826,差异0.116(95%CI 0.068-0.164,P<.001)。
  • AHA/ACC D-E对肺栓塞相关死亡敏感性83.8%、特异性95.1%;ESC高危层敏感性58.8%、特异性95.8%。
  • 去除AHA/ACC类别A和E后,30天AUC差异为0.112(95%CI 0.038-0.186)。

临床怎么用

  • 在住院急性肺栓塞预后评估中,可考虑使用AHA/ACC分类以更好识别短期死亡高风险患者。
  • AHA/ACC D-E但ESC中危的患者早期死亡风险高,需加强监护与治疗强度。
  • ESC高危定义侧重血流动力学不稳定,可能漏判部分观察死亡风险高的患者。

局限性

  • 研究为回顾性设计,仅反映观察治疗下的预后判别性能。
  • 肺栓塞相关死亡由机构判定,属事后分析。
  • 单国双院区队列,外推性需进一步验证。
  • AHA/ACC与ESC判别差异依赖疾病严重谱范围,去除极端类别后差异缩小。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The 2026 American Heart Association/American College of Cardiology (AHA/ACC) and 2019 European Society of Cardiology (ESC) pulmonary embolism (PE) classifications represent severity differently: AHA/ACC spans subclinical PE through cardiopulmonary failure, whereas ESC defines high risk by hemodynamic instability. Their prognostic separation is uncertain. RESEARCH QUESTION: How do these classifications compare in mortality discrimination and identification of patients at high observed risk in hospitalized acute PE? STUDY DESIGN AND METHODS: We retrospectively studied 2,251 patients at a two-campus Chinese tertiary hospital (2013-2025). Index time was admission for community-acquired PE and symptom onset or first objective imaging for hospital-acquired PE. The primary outcome was 30-day all-cause mortality; institutionally determined PE-related mortality was post hoc. Paired DeLong tests compared ordinal areas under the receiver operating characteristic curves (AUCs), and AHA/ACC categories D-E defined the analysis high-risk threshold. RESULTS: 127 patients (5.6%) died within 30 days and 80 (3.6%) had PE-related death. Thirty-day AUCs were 0.885 (95% confidence interval [CI], 0.858-0.912) for AHA/ACC and 0.763 (95% CI, 0.721-0.806) for ESC (difference, 0.122; 95% CI, 0.084-0.160; P < .001). PE-related mortality AUCs were 0.942 and 0.826, respectively (difference, 0.116; 95% CI, 0.068-0.164; P < .001). At the analysis-defined high-risk thresholds, sensitivities for PE-related death were 83.8% for AHA/ACC categories D-E and 58.8% for the ESC high-risk stratum, with specificities of 95.1% and 95.8%, respectively. Among 37 patients in AHA/ACC categories D-E but the ESC intermediate-risk stratum, 75.7% died by 30 days and 54.1% had PE-related death. Excluding AHA/ACC A and E attenuated the 30-day AUC difference to 0.112 (95% CI, 0.038-0.186). INTERPRETATION: Under inpatient care, the AHA/ACC categories showed greater full-spectrum ordinal separation and identified a phenotype with substantial observed mortality risk that was not classified as ESC high risk. Attenuation within the central severity range indicated that the difference was spectrum dependent. TAKE HOME POINTS: Study Question:How do the 2026 AHA/ACC Acute PE Clinical Categories and the 2019 ESC scheme compare for short-term mortality prognosis in hospitalized acute PE? RESULTS: AHA/ACC showed greater full-spectrum ordinal separation for 30-day all-cause and institutionally determined PE-related mortality and identified an ESC intermediate-risk subgroup with high early mortality, although the difference attenuated when the AHA/ACC severity extremes were removed. INTERPRETATION: The findings suggest that broader severity phenotyping may identify clinically important discordance while remaining limited to prognostic performance under observed care.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Fan J, He J, Wang M, et al. Comparative Short-Term Prognostic Discrimination of the 2026 AHA/ACC and 2019 ESC Risk Classifications in Hospitalized Acute Pulmonary Embolism: A Retrospective Two-Campus Cohort Study. Chest. 2026. PMID: 42810427. doi:10.1016/j.chest.2026.09.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。